Classically, immunotoxicology has been defined as the study of adverse effects on the immune system associated with exposure to environmental chemicals, pharmacologic agents, and biologicals. Although a multitude of immune system defects may occur, these can be generally categorized as immunomodulation (immune suppression or potentiation), hypersensitivity (i.e., allergy), and autoimmunity. We present here a brief synopsis of the ontogeny of immunotoxicology as a discipline including methodology currently used in our laboratory, as well as in others, for investigating the immunomodulatory potential of chemicals at the cellular and biochemical level. Additionally, we summarize some studies related to the immunosuppressive effects of one particular compound, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Last we discuss potential future directions and challenges in the field of immunotoxicology.
Background
Immunotoxicology can be defined as the study of the adverse effects of environmental chemicals, certain therapeutics, and biologicals on the immune system. The adverse effects that may occur include immunomodulation (i.e., suppression or potentiation), hypersensitivity (i.e., allergy), and, in rare instances, autoimmunity. Although chemical-induced autoimmune diseases are not well documented, the extent of chemical-induced hypersensitivity has been known for a long time (1, 2) . Some of the industrial materials with known or presumed allergic etiology are shown in Table 1 . More recently, a large body of information has also developed demonstrating that exposure to certain chemicals or drugs can produce immunosuppression in experimental animals (Thble 2) (3) (4) (5) . In contrast to immunosuppressive drugs, however, only a limited number of reports indicate immune dysfunction following a human exposure to chemical xenobiotics.
The sensitivity of the immune system to these chemicals is probably due as much to the general properties of the xenobiotic (eg. reactivity with macromolecules) as to the complex nature of the immune system, which encompasses antigen recognition and processing; cellular interactions involving cooperation, regulation, and amplification; cell activation, proliferation, and differentiation; and mediator production. The immunosuppressive effects associated with exposure to xenobiotics are often accompanied by increased susceptibility to challenge with infectious agents or tumor cells. Although only limited studies in humans have been conducted, effects similar to those observed in rodents have been reported in several instances following therapeutic, inadvertent, or occupational exposure to xenobiotics exemplifying characteris-T'able 1 tics of secondary immunodeficiency disease. Among these effects include altered immune responses in Michigan residents and farmers exposed to polybrominated biphenyls (PBBs) through the consumption of contaminated livestock and dairy products (6); Chinese and Japanese exposed to polychlorinated biphenyls (PCBs) and dibenzofurans through contaminated rice oil used in cooking (7); Spanish residents exhibiting "toxic oil syndrome" following ingestion of isothiocyanate-derived imidazolidinethione adulterated rapeseed oil (8) ; factory workers with aplastic anemia and leukemia occupationally exposed to benzene (9) ; and AIDS patients who develop myelotoxicity following azidothymidine (AZT) therapy (10 
Methodology
The immune system is a complex network comprised of several cell types (i.e., lymphocytes, macrophages, granulocytes, and natural killer cells) whose variety of functions include maintaing homeostasis and health. The mode of its activity resembles that of the endocrine system in that circulating cellular and soluble components can act at sites far removed from their point of origin. The system continuously undergoes proliferation and differentiation. Its primary responsibility is the defense against invasion by pathogenic microbial agents and spontaneously arising neoplasms. In doing so, the intensity and specificity of the immune response must be highly regulated and capable of discerning self from nonself.
Since the immune system is a complex organization of cells with a variety of functions, appropriate evaluation of chemical-mediated effects necessitates the examination of multiple immune functions. One of the focuses among immunotoxicologists has been the development and implementation of a tiered panel of assays to identify im- (Table 3 ). This testing configuration has undergone a 4-year developmental and interlaboratory validation period (12) and is now routinely used to evaluate the potential of therapeutic or environmental chemicals to modulate immune function in mice. Immune testing configurations have also been described in rats (13, 14) . The assays listed under Tier I represent a simple screen and include measurements for cell-mediated immunity (CMI), humoral-mediated immunity (HMI), and natural killer (NK) cell activity, as well as immunopathology, the latter of which is part of the standard protocol in subchronic studies conducted by the NTP. The likelihood of detecting potent immunotoxicants using Tier I is high, but will decrease for weaker immunotoxicants, such as those that affect only a specific cell population or subpopulation. Nonetheless, based upon the data from compounds that have completed both Tier I and II testing, no compound has been found to affect an assay in Tier II without demonstrating some effect on Tier I.
The assays listed in Tier II, which allow more flexibility than Tier I, represent a more comprehensive evaluation of the immune system, more likely to identify affected cell types. Criteria usually fulfilled prior to initiating tests in Tier II Regarding CMI, we have examined both delayed hypersensitivity responses (DHRs) and cytotoxic T-lymphocyte (CTL) activity, and accumulating evidence indicates that the latter provides more sensitivity and reproducibility for assessing chemical-induced immunotoxicity. The use of multiple assays in a testing configuration allows the establishment of an immune profile similar to that used to diagnose primary or acquired immunodeficiency diseases. Because of the variability in some of the immune responses, an alteration in a single parameter is normally insufficient to label a compound as immunotoxic. Details describing these methodologies are published elsewhere (12, 15) .
Host resistance models were developed to evaluate the relationship between the immune function tests and more biologically relevant end points (16, 17) . This was particularly important if the immunological data are to be used in risk assessment evaluation. The host resistance models listed in Table 3 have been correlated with immune function assays using data from animals exposed to approximately 15 chemicals over a 4-year period ( 
Immunotoxic Xenobiotics
Of the list of immunotoxic compounds shown in Table  2 , one of the most extensively studied classes of environmental chemicals examined for immunotoxicity in experimental animals or humans is the halogenated aromatic hydrocarbons (HAHs), and, in particular, polychlorinated biphenyls (PCBs), polybrominated biphenyls (PBBs), dibenzo-p-dioxins, and dibenzofurans. Despite the species variability associated with the toxicity of these compounds, studies in laboratory animals exposed during neonatal or adult life with HAHs and, in particular, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), have indicated that the immune system is one of the most sensitive targets for toxicity (5, (18) (19) (20) (19) , a feature characteristic of undifferentiated T-cells. Furthermore, in vitro studies using a thymocyte and thymic epithelial cell coculture system have shown that pretreatment of thymic epithelial cell monolayers with TCDD inhibits their ability to stimulate T-cell differentiation (21) . With the use of murine bone-marrow chimeras, it has been shown that inhibition of CILs by subchronic TCDD exposure is due to the Ah genotype of the host and not of the grafted stem cell, further supporting involvement of a secondary tissue (22) . In contrast to subehronic or perinatal exposure, acute exposure of adult rodents to HAHs has its major effect on rapidly proliferating cell populations, including hematopoietic stem cells and B-lymphocytes, the effect manifested as suppressed antibody responses. Unlike CMI, TCDD inhibits hematopoiesis and B-cell function by directly inhibiting maturation of the B-lymphocytes or bone marrow stem cell.
Myelotoxicity, thymic atrophy, and immunosuppression by TCDD and PCBs appear to be associated with stereospecific binding to the Ah receptor, which is present at low concentrations in both lymphoid tissue and lymphoid cells (5) . This has been supported in genetic studies using Ah-responsive and -nonresponsive mouse strains, including mouse strains congenic at the Ah locus, where the immunotoxic effects of TCDD segregate with the Ah genotype. This can be seen in Figure 1 , where a dosedependent suppression of the antibody response to trinitrophenylated-lipopolysaccharide antigen occurred when purified splenic B-cells obtained from Ahresponsive mice were cultured with TCDD, but not when TCDD was cultured with cells from the nonresponsive strain. In contrast, dexamethasone, another potent immunosuppressant that acts via a steroid receptor mechanism, did not show these strain differences. In addition to genetic studies, structure-activity studies showed that the binding affinity of various HAH congeners to the Ah receptor correlates with their potency to induce immunosuppression.
Although immunotoxicity by HAHs is mediated through binding to the Ah receptor, the mechanisms responsible for toxicity following interaction of the receptor-ligand complex with the Ah locus are unknown. In fact, additional loci may be involved, as certain tissue- 
Conclusions and Future Direction
The immune system is composed of several cell populations where maturation of each population is subject to orderly control by endogenous hormones and exogenous bacterial products. These mediators possess activation, growth-promotion, and/or differentiation properties, and are under the influence of potent, but not well-understood regulators. From observations in rodents and limited studies in humans inadvertently exposed, it is apparent that a number of xenobiotics adversely affect the immune system. This can occur through disruption of cell maturation or regulation, as well as through cytotoxic processes. These examples, combined with our currect knowledge about the pathogenesis of disease, support the possibility that chemical-induced damage to the immune system may be associated with a wide spectrum of diverse pathological conditions, some of which may only become detectable after a long latency. Likewise, exposure to immunotoxic xenobiotics might represent additional risks to individuals with already fragile immune systems (e.g., malnutrition, infancy and old age). However, it is important that caution be exercised when attempting to extrapolate meaningful conclusions from experimental data or isolated epidemiological studies to risk assessment for low-level human exposure.
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